Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 77, Issue 2, 2011, Pages 265-274

  Markoutsa, Eleni ^a   Pampalakis, Georgios ^a   Niarakis, Anna ^a   Romero, Ignacio A ^b   Weksler, Babette ^c   Couraud, Pierre Olivier ^d   Antimisiaris, Sophia G ^a,e  

^a UNIVERSITY OF PATRAS   (Greece)

^b OPEN UNIVERSITY   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d INSTITUT COCHIN   (France)

^e INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Blood brain barrier; Dual targeting; Immunoliposomes; OX 26 antibody; Transcytosis; Transferrin

Indexed keywords

BIOTIN; IMMUNOLIPOSOME; NANOPARTICLE; STREPTAVIDIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLUORESCENCE; HUMAN; HUMAN CELL; LIPID MEMBRANE; LYSOSOME; NONHUMAN; PH; TRANSCYTOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULIN G; LIPOSOMES; MICE; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; PHYSICOCHEMICAL PHENOMENA; RECEPTORS, TRANSFERRIN; TRANSCYTOSIS; TRANSFERRIN;

EID: 79551568741     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.11.015     Document Type: Article

References (41)

1. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
2. W.M. Pardridge Drug targeting to the brain Pharm. Res. 24 2007 1733 1744
3. L. Juillerat-Jeanneret The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13 2008 1099 1106
4. J. Huwyler, D. Wu, and W.M. Pardridge Brain drug delivery of small molecules using immunoliposomes Proc. Natl. Acad. Sci. USA 93 1996 14164 14169
5. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81
6. J. Kreuter Influence of the surface properties on nanoparticle mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 2004 484 488
7. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K. Cychutek, C. Koch- Brandt, and R. Alyautdin Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Target. 10 2002 317 325
8. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, S. Wagner, C. Buchel, H. von Briesen, and J. Kreuter Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurons J. Control. Release 137 2009 78 86
9. H.R. Kim, K. Andrieux, S. Gil, M. Taverna, H. Chacun, D. Desmaële, F. Taran, D. Georgin, and P. Couvreur Translocation of poly(ethylene glycol-cohexadecyl) cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis Biomacromolecules 8 2007 793 799
10. J. Chang, Y. Jallouli, M. Kroubi, X. Yuan, W. Feng, C-S. Kang, P-Y. Pu, and D. Betbeder Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier Int. J. Pharm. 379 2009 285 292
11. A.S. Abu Lila, T. Ishida, and H. Kiwada Targeting anticancer drugs to tumor vasculature using cationic liposomes Pharm. Res. 27 2010 1171 1183
12. S.G. Antimisiaris, P. Kallinteri, and D. Fatouros Liposomes and drug delivery S.C. Gad, Pharmaceutical Manufacturing Handbook Production and Processes 2008 Springer Berlin 443 533
13. R.M. Straubinger, D. Papahadjopoulos, and K. Hong Endocytosis and intracellular fate of liposomes using pyranine as a probe Biochemistry 29 1990 4929 4939
14. D.L. Daleke, K. Hong, and D. Papahadjopoulos Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay Biochim. Biophys. Acta 1024 1990 352 366
15. A. Safavy, K.P. Raisch, D. Matusiak, S. Bhatnagar, and L. Helson Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule Bioconjugate Chem. 17 2006 565 570
16. T.L. Andresen, S.S. Jensen, and K. Jørgensen Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumour specific drug release Prog. Lipid Res. 44 2005 68 97
17. J.M. Stukel, R.C. Li, H.D. Maynard, and M. Caplan Two-step synthesis of multivalent cancer-targeting constructs Biomacromolecules 11 2010 160 167
18. Y. Zhang, C. Zhu, and W.M. Pardridge Antisence gene therapy of brain cancer with an artificial virus gene delivery system Mol. Ther. 6 2002 67 72
19. P.H. Tan, M. Manunta, N. Ardjomand, S.A. Xue, D. F Larkin, and D.O. Haskard J. Gene Med. 5 2003 311 323
20. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferring-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 71 2009 251 256
21. A. Schnyder, S. Krahenbuhl, M. Torok, J. Drewe, and J. Huwyler Targeting of skeletal muscle in vitro using biotinylated immunoliposomes Biochem. J. 377 2004 61 67
22. L.L. Rubin, D. E Hall, and S. Porter A cell culture model of the blood-brain barrier J. Cell Biol. 115 1991 1725 1735
23. J. Huwyler, J. Drewe, C. Klusemann, and G. Fricker Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium Br. J. Pharmacol. 118 1996 1879 1885
24. M. Torok, J. Huwyler, H. Gutmann, G. Fricker, and J. Drewe Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions Exp. Brain Res. 153 2003 356 365
25. F. Roux F, O. Durieu-Trautmann, N. Chaverot, M. Claire, P. Mailly, J.M. Bourre, A.D. Strosberg, and P.O. Couraud Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells J. Cell. Physiol. 159 1994 101 113
26. A. Regina, I.A. Romero, J. Greenwood, P. Adamson, J.M. Bourre, P.O. Couraud, and F. Roux Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT J. Neurochem. 73 1999 1954 1963 (Pubitemid 29491808)
27. Y. Omidi, L. Campbell, J. Barar, D. Connell, S. Akhtar, and M. Gumbleton Evaluation of the immortalized mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies Brain Res. 990 2003 95 112
28. B.B. Weksler, E.A. Subileau, and N. Perriere FASEB J. 19 2005 1872 1874
29. R. Poller, H. Gutman, S. Krahenbuhl, B. Weksler, I. Romero, P.O. Couraud, G. Tuffin, J. Drewe, and J. Huwyler The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies J. Neurochem. 107 2008 1358 1368
30. D. Brambilla, J. Nicolas, B. Le Droumaguet, K. Andrieux, V. Marsaud, P.-O. Couraud, and P. Couvreur Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging Chem. Commun. 46 2010 2602 2604
31. N. Chattopadhyay, J. Zastre, H.-L. Wong, X.Y. Wu, and R. Bendayan Solid lipid nanoparticles enhance the delivery of the HIV pretease inhibitor, Atazanavir, by a human brain endothelial cell line Pharm. Res. 25 2008 2262 2271
32. S. Mourtas, S. Duraj, S. Fotopoulou, and S.G. Antimisiaris Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels Coll. Surf. B: Biointerfaces 61 2008 270 276
33. H. Loughrey, M.B. Bally, and P.R. Cullis A non-covalent method of attaching antibodies to liposomes Biochim. Biophys. Acta 910 1987 157 160
34. J.C. M Stewart Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal. Biochem. 104 1980 10 14
35. M. Kokona, P. Kallinteri, D. Fatouros, and S.G. Antimisiaris Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition Eur. J. Pharm. Sci. 9 2000 245 252
36. D. Kiprotin, J.W. Park, K. Hong, S. Zalipsky, W.L. Li, P. Carter, C.C. Benz, and D. Papahadjopoulos Sterically stabilized Anti-Her2 Immunoliposomes: design and targeting to human breast cancer cells in vitro Biochemistry 36 1997 66 75
37. E.K. Agyare, G.L. Curran, M. Ramakrishnan, C.C. Yu, J.F. Poduslo, and K.K. Kandimalla Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimers disease and cerebral amyloid angiopathy Pharm. Res. 25 2008 2674 2684
38. X. Ying, H. Wen, W.-L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.-J. Li, T.-Y. Yang, D.-W. Shang, J.-N. Lou, L.-R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
39. A. Cerletti, J. Drewe, G. Fricker, A.N. Eberle, and J. Huwyler Endocytosis and transcytosis of an immunoliposomes-based brain drug delivery system J. Drug Target. 8 2000 435 446
40. S.V. Vinogradov, E.V. Batrakova, and A.V. Kabanov Nanogels for oligonucleotide deliver to the brain Bioconjugate Chem. 15 2004 50 60
41. I. Van Rooy, S. Cakir-Tascioglu, P.O. Couraud, I.A. Romero, B. Weksler, G. Storm, W.E. Hennink, R.M. Schiffelers, and E. Mastrobattista Identification of peptide ligands for targeting to the blood-brain barrier Pharm. Res. 27 2010 673 682